- Home
- LVWR vs CGEM Comparison
LVWR vs CGEM Comparison
Compare LVWR & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- CGEM
- Stock Information
- Founded
- LVWR 2022
- CGEM 2016
- Country
- LVWR United States
- CGEM United States
- Employees
- LVWR N/A
- CGEM N/A
- Industry
- LVWR
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- LVWR
- CGEM Health Care
- Exchange
- LVWR Nasdaq
- CGEM Nasdaq
- Market Cap
- LVWR 892.3M
- CGEM 730.2M
- IPO Year
- LVWR N/A
- CGEM 2021
- Fundamental
- Price
- LVWR $4.12
- CGEM $10.26
- Analyst Decision
- LVWR Hold
- CGEM Strong Buy
- Analyst Count
- LVWR 1
- CGEM 7
- Target Price
- LVWR $7.25
- CGEM $31.67
- AVG Volume (30 Days)
- LVWR 35.7K
- CGEM 614.7K
- Earning Date
- LVWR 02-05-2025
- CGEM 03-13-2025
- Dividend Yield
- LVWR N/A
- CGEM N/A
- EPS Growth
- LVWR N/A
- CGEM N/A
- EPS
- LVWR N/A
- CGEM N/A
- Revenue
- LVWR $30,963,000.00
- CGEM N/A
- Revenue This Year
- LVWR $3.44
- CGEM N/A
- Revenue Next Year
- LVWR $136.41
- CGEM N/A
- P/E Ratio
- LVWR N/A
- CGEM N/A
- Revenue Growth
- LVWR N/A
- CGEM N/A
- 52 Week Low
- LVWR $4.01
- CGEM $9.50
- 52 Week High
- LVWR $11.69
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- LVWR 32.07
- CGEM 34.25
- Support Level
- LVWR $4.25
- CGEM $9.50
- Resistance Level
- LVWR $4.67
- CGEM $11.31
- Average True Range (ATR)
- LVWR 0.33
- CGEM 0.77
- MACD
- LVWR -0.02
- CGEM -0.11
- Stochastic Oscillator
- LVWR 9.82
- CGEM 21.79
About LVWR LiveWire Group Inc.
LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.